Comparison of the Effects of Public and Private Health Expenditures on the 

Health Status: A Panel Data Analysis in Eastern Mediterranean Countries by Homaie Rad, Enayatollah et al.
Original Article
Comparison of the Effects of Public and Private Health Expenditures on the 
Health Status: A Panel Data Analysis in Eastern Mediterranean Countries
Enayatollah Homaie Rad1, Sajad Vahedi2, Abedin Teimourizad2, Firooz Esmaeilzadeh2, Mohamad Hadian2,*, Amin 
Torabi Pour3
1School of Health Management and Information Sciences, Tehran University of Medical sciences, Tehran, Iran
2School of Health Management and Information Sciences, Shiraz University of Medical sciences, Shiraz, Iran
3School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Background: Health expenditures are divided in two parts of public and private health expenditures. 
Public health expenditures contain social security spending, taxing to private and public sectors, and 
foreign resources like loans and subventions. On the other hand, private health expenditures contain out 
of pocket expenditures and private insurances. Each of these has different effects on the health status. 
The present study aims to compare the effects of these expenditures on health in Eastern Mediterranean 
Region (EMR).
Methods: In this study, infant mortality rate was considered as an indicator of health status. We estimated 
the model using the panel data of EMR countries between 1995 and 2010. First, we used Pesaran CD test 
followed by Pesaran’s CADF unit root test. After the confirmation of having unit root, we used Westerlund 
panel cointegration test and found that the model was cointegrated and then after using Hausman and 
Breusch-Pagan tests, we estimated the model using the random effects.
Results: The results showed that the public health expenditures had a strong negative relationship with 
infant mortality rate. However, a positive relationship was found between the private health expenditures 
and infant mortality rate (IMR). The relationship for public health expenditures was significant, but for 
private health expenditures was not.
Conclusion: The study findings showed that the public health expenditures in the EMR countries 
improved health outcome, while the private health expenditures did not have any significant relationship 
with health status, so often increasing the public health expenditures leads to reduce IMR. But this 
relationship was not significant because of contradictory effects for poor and wealthy peoples.
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Background
According to the economic growth literature, improvement in 
human capital is one of the most important factors in achieving 
economic growth and development (1). In the neoclassical 
growth model, increasing the human capital will raise the per 
capita product. Also, based on Grossman’s human capital model, 
health increases the human capital by making more time for 
working and increasing utility (2). Nowadays, increasing the 
individuals’ health level is one of the most important policies 
to provide social equity in countries. Health is the center of 
sustainable development; therefore, considering health and 
making attempts for its improvement and expansion have 
always been a priority (3). Therefore, investment in health is 
very important in many countries. Health expenditures contain 
all the expenditures which are used for preparing and improving 
the individuals’ health (4). The concept of health expenditures 
is different from one country to another. Moreover, Poullier 
has divided total health expenditures in two parts of public and 
private health expenditures. Public health expenditures contain 
social security spending, taxing to private and public sectors, 
and foreign resources like loans and subventions. On the 
other hand, private health expenditures contain private health 
insurance, out-of-pocket health expenditures, etc (5–7).
In order to enhance health, sufficient health recourses must 
be prepared. Preparing these resources need money, hence 
achieving a healthy country requires health spending (8). 
Health expenditures increase the quality of human resources 
and lead to higher life expectancy as well as longevity (9). An 
Increase in life expectancy also leads to an increase in the desire 
of saving and investing and eventually results in higher rates 
of economic growth (10). However, researchers have come to 
the conclusion that public health expenditure, especially in 
developing countries, plays an important role in reaching to 
some millennium development goals such as achieving universal 
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primary education, promoting gender equality empowering 
women, reducing poverty and disparity, and confronting the 
deadly diseases (e.g. AIDS, malaria and tuberculosis). However, 
in most developing countries, governors do not pay attention to 
health and do not give it an enough share in the budget (11). For 
example, data have shown that the share of health expenditures 
in government budget was 7.02% in Lebanon, 8.04% in Jordan, 
only 2.19% in Pakistan, and 2.75% of GDP in Oman in 2010 
(12).
Each of the private and public health expenditures has different 
effects on the health status. Increase in out of pocket health 
expenditure, which is one of the private health expenditures, 
increases the number of catastrophic expenditures and may lead 
to more poverty (13); of course, in some countries governors like 
private health expenditures. For instance, they do not have to 
pay for people and the lack of budget will decrease (14). Higher 
private health expenditures lead to increase the costs of the 
insurers’ management and marketing and they must take much 
more money from their customers. Therefore, people do not have 
to pay more for something which makes them healthier, nor does 
it protect them against the expensive health expenditures. On 
the other hand, because of having a competitive health insurance 
system, in order to have a larger number of costumers, insurers 
deliver a variety of services providing the costumers with the 
opportunity to select what they really want (15). Increasing the 
public health expenditure may increase the budget shortage, but 
it decreases the number of catastrophic expenditures. Public 
health expenditure improves the society’s health and eventually 
improves human capital and leads to economic growth. Thus, 
in order  to  assess  the  humane capital, analysts look at the 
government’s share of the health expenditures (16). The present 
study aims to investigate the effects of public and private health 
expenditures on the health status in the Eastern Mediterranean 
Region (EMR) countries. Total health expenditures in these 
countries have been increased resulting in an increase in the 
health status. The increase in the health status is different from 
one country to another; some of them have been very successful 
in changing the health status, while some have not. In Iran 
for example, the total health expenditures per capita has been 
quadruplicated from $209.71 at purchasing power parity in 
1995 to $836.27 in 2010, while the infant mortality rate (IMR) 
has decreased only from 5.48 to 5.04 in these years. In Egypt, 
the total health expenditure per capita increased from $108.71 
in 1995 to 288.56 in 2010 and there was a big change in infant 
mortality rate, too (from 7.063 in 1995 to 5.121 in 2010) (17). 
These differences show that in the relationship between the 
health status and health expenditures, we should take into 
account not only the total health expenditures but also the share 
of public and private health expenditures. Studying the effects 
of public and private health expenditures and their effects on 
health status will help policy makers to make correct decisions 
in their decision making. This article shows the importance of 
each of the public or private health expenditures in changing 
health status of the population.
Methods
Data
Panel data econometrics method was used in the present 
descriptive-analytical study. In this study, we used a panel data 
from 1995 to 2010 from the 20 EMR countries. These countries 
are: Afghanistan, Bahrain, Djibouti, Egypt, Iran, Iraq, Jordan, 
Kuwait, Lebanon, Libya, Morocco, Oman, Qatar, Saudi Arabia, 
Somalia, Sudan, Syria, Tunisia, United Arab Emirates, and 
Yemen. Data for other EMR countries (South Sudan, Palestine) 
were not available. The data related to 2011 and 2012 were not 
available for some indicators; therefore, we decided to exclude 
these years. The data were gathered from World Bank statistical 
data bank (12).
Model
We used the following matrix form model:
Yit = β Xit + uit        (1)
Where Yit is the dependent variable and shows the level of 
health in the time of t and in the country of i. In general, many 
indicators, such as quality of life, life expectancy, health adjusted 
life expectancy, infant mortality rate, and maternal mortality 
rate, can be used in order to show the health status. In this 
study, infant mortality rate was used as the indicator of health 
status because its data were available in all the EMR countries 
and it is the WHO indicator for specifying the countries’ 
health status. We used some determinants of infant mortality 
rate at the national level. In our model, Xit is the matrix form 
for explanatory variables and uit contains the residuals. The 
econometrics model of this study is in Cobb-Douglas form and 
has been presented blew. This model was used by Frey and Field 
and Homaie Rad et al (18,19):
Hit = α iPub itβ1Pvtit β2gdpitβ 3POPU1itβ 4FLBitβ5FERitβ6EDU itβ7URBitβ8 u it,               (2)
Where:
Hitit: infant mortality rate of the countries
PUBit: public health expenditures per capita at purchasing 
power parity
PVTit: private health expenditures per capita at purchasing 
power parity
GDPit: gross domestic product per capita at purchasing power 
parity
POPU1it: proportion of the population under 15 years old
POPU2it: proportion of the population between 15 to 64 years 
old
FLBit: female labour participation rate
FERit: fertility rate
EDUit: mean years of school for the people above 25 years old
URBit: proportion of the population who lives in urban regions
Because of having a Cobb-Douglas model, we must make the 
model estimable. In doing so, we must take the logarithm of the 
two parts of the model and make it a linear one.
lHit=α i+β1lpubit+β2 lpvtit+β3lgdpit+ β5lpopU1it+β6lflbt+ Β7lferit+β8ledu 
it+β9lurbit+uit,   (3)
Where l shows the logarithm form of each variable. Because 
of having long time series (16 years) and long cross sections 
(20 countries), before each estimation, we must test the cross 
sectional dependency as well as the unit roots. If the model has 
cross sectional dependency, using common panel data unit root 
and cointegration tests may lead to spurious results. Therefore, 
we must use the tests which are designed for cross sectional 
dependent models. In the present study, we made use of STATA 
11 (College Station, TX, USA) for using the tests and estimating 
the model.
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Estimating techniques
For  indicating  the presence of cross sectional dependency, we 
used Pesaran cross sectional dependency test (20). After that, 
we used CIPS test to determine whether the variables were unit 
root or not (21). After being ascertained about having non-
stationary variables, we used cointegration tests which are used 
to show if there is a long term relationship between the variables. 
If we estimate a non-cointegration model with non-stationary 
variables, the model will lead to spurious results. In this study, 
Westerlund panel cointegration tests were utilized in order to 
assess the presence or absence of cointegration  (22). This test 
contains 4 various tests named Ga, Gt, Pa, and Pt. All these 
tests use a bootstrap technique to eliminate the cross sectional 
dependency (23). Finally, the model was estimated. In order to 
estimate the model, first we used Hausman test. This test shows 
whether the model has fixed or random effects. Then, we used 
Breusch-Pagan test to determine whether the model was a 
pooled or a panel one. 
Results
Table 1 shows the results of descriptive statistics for other 
variables. In the EMR countries, mean IMR was 33.98 per 1000 
births between 1995 and 2010 with the range of 6 to 108.50. 
Minimum of this range was for United Arab Emirates in 2010 
and the maximum was for Afghanistan in 1995. The average of 
Per capita public health expenditure was 316.20 and the average 
of per capita private health expenditure was 360.71. Minimum 
and maximum of these two variables were 0.12 and 2535.05 for 
public and 0.652 and 8529.56 for private health expenditure. The 
minimum and maximum of the range for both per capita public 
and private health expenditures were for Iraq in 1997 and Qatar 
in 2003.
Table 2 shows the results of Pesaran’s cross sectional 
dependency test.  As  shown  in the table, all the study variables 
were rejected regarding the hypothesis of not having cross 
sectional dependency. Now, we cannot use unit root tests 
without paying attention to cross sectional dependency. Thus, 
Pesaran’s CADF unit root test was utilized. The null hypothesis 
of this test is having non-stationary variables. Table 3 shows the 
results of this test.
In the current study, Westerlund panel cointegration test was 
used to show whether there was a long run relationship among 
Table 1.Descriptive statistics
Variable Mean Standard error Min Max
IMR 33.98 1.46 6.00 108.50
Pvt 360.71 55.59 0.65 8529.56
Pub 316.20 22.18 0.12 2535.05
GDP 13280.33 892.80 595.04 76900.52
Popu1 34.67 0.44 13.48 50.90
Popu2 60.38 0.45 46.33 85.48
Urb 64.97 1.27 19.34 98.65
Flab 24.78 0.54 10.40 52.10
Edu 3.91 0.12 0.20 8.70
Fer 3.64 1.46 1.67 8.06
the variables. As mentioned before, Westerlund uses a bootstrap 
technique to eliminate cross sectional dependency in the model. 
Table 4 shows the results of Westerlund cointegration tests. We 
also have to consider the results which have been obtained 
through the bootstrap technique. The presence of a cointegrated 
model has been confirmed in all these 4 tests because the null 
hypothesis of having a cointegration model is accepted in these 
tests.
Now, we can estimate the model without any disturbance. For 
estimating the model, we must choose between the pooled–
panel effects and fixed–random ones. We used Breusch-Pagan 
test to find the pooled or panel effects. The χ2 statistics of this 
test was 1618 and its P was 0.00; therefore, random effects had 
to be selected. We used Hausman test to select between the 
fixed and random effects (P=0.13); therefore, random effects 
were used for estimating the model. Table 5 shows the results of 
estimating the model using random effects. The R2 statistics for 
this model is 0.90 and it is good for panel data models. In the 
table, you can see the results of coefficients, t statistics and P. As 
the table depicts, except for Logarithm of mean years of school 
for the people above 25 years old (LEDU), all the variables had 
relationships with logrithm of infant mortality rate (LIMR). 
Some of these variables (lpub, lgdp, lpopu2, lflab, lfer) are 
significant at 95% confidence interval and others are significant 
at 90%. The study results revealed negative relationships 
between public health expenditures, GDP, proportion of the 
population between 15 to 64 years old, and infant mortality rate. 
This indicates that if the public health expenditures and GDP 
increase, the status of health will increase, as well. However, 
a significant positive relationship was found between private 
health expenditures and IMR. Private health expenditures 
contain some health expenditures, such as out of pocket health 
expenditures and private health insurance. In addition, for 
poorer families increasing the out of pocket expenditures may 
lead to catastrophic health expenditures and increasing poverty 
which eventually results in an increase in infant mortality rate. 
In wealthy families, using private health insurance is better 
because they can select from various services leading to increase 
in the health status rate. The opposing effect of private health 
Table 2. The results of Pesaran cross sectional dependency test
Variable CD-test P     
Lpvt 15.76 0.00   
Lpub 31.98 0.00    
Lgdp 38.74 0.00    
Lpopu1 46.86 0.00    
Lpopu2 47.17 0.00    
Lurb 42.24 0.00    
Lflab 25.88 0.00
Ledu 54.28 0.00
Table 3. The results of Pesaran CADF unit root test
Variable t-bar cv5       P
Lpvt -1.475  -2.210  0.87
Lpub -1.959 -2.210    0.16
Lgdp -2.532  -2.210    0.00
Lpopu1 -0.856 -2.210    1.00
Lpopu2 -1.745   -2.210    0.47
Lurb -0.252  -2.210    1.00
Limr  -2.925 -2.210    0.00
Ledu -2.125 -2.210 0.04
Lflab -1.836 -2.210 0.32
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expenditures on poor and wealthy families is the reason why the 
private health expenditures do not have a significant relationship 
with infant mortality rate at 5%. According to the study results, 
the coefficient of private health expenditures was positive. This 
is because there are more poor families in the EMR countries 
and increasing the private health expenditures decreases the 
health status of the society. The study findings also revealed 
a significant positive relationship between the proportion of 
people under 14 years old and IMR. This might be due to the 
fertility rate; when the average number of children that would 
be born to a woman over her lifetime increases, infant mortality 
rate increases, too. However, the relationship was shown to be 
negative for other age groups. Overall, increasing longevity is 
the result of having a healthy society.
Discussion
The findings of the present study showed a positive relationship 
between public health expenditures and health status, while a 
negative one was observed between private health expenditures 
and health status; of course, this relationship for public health 
expenditure was significant at 5% and for private health 
expenditure this relationship was significant at 10%. Novignon 
et al. found similar results regarding public health expenditures. 
In their study, they used a panel data for 44 African countries. 
Unlike our study, however, they found a significant positive 
relationship between private health expenditures and health 
status (24). Moreover, Asiskovitch et al. used the panel data for 
OECD countries and showed that in comparison to the private 
health expenditures, public health expenditures had a stronger 
relationship with the health status (25), which is in agreement 
with the results of the present study. In a study which was 
performed in Latin America, the relationship between public 
Table 5. The results of estimating the model with OLS random effects
Variables Coef Z    P
Lpvt 0.02 1.85 0.06    
Lpub -0.02   -1.98   0.05
Lgdppp -0.30 -6.84    0.00
Lpopu1 0.13 1.87 0.06
Lpopu2 -1.58 -9.06 0.00
Lurb 0.26 1.69 0.09
Lflab 0.18 3.55 0.00
Lfer 0.80 1.19 0.00
Ledu 0.04 0.81 0.42
Cons 9.17 7.91 0.00
R2=0.90,    Breusch-Pagan  χ2= 1618,   Hausman P = 0.13
and private health expenditures and income was analysed. If 
the health status is improved, people can work more and earn 
much more money. In this study, in both the public and private 
sectors, the health expenditures per capita was positively and 
significantly correlated with income per capita (26). Cremieux 
et al. evaluated the effect of private and public pharmaceutical 
expenditures on the health status in Canada. In contrast to our 
study, they found that private expenditures had more positive 
effects on the health status compared to the public health 
expenditures (27). Following Cremieux et al., Guidon et al. used 
the panel data cointegration approach to find the relationship 
between the pharmaceutical expenditures and the health 
status in Canada. However, they did not find any significant 
relationships between these health expenditures and the health 
status indicators (28). On the other hand, Nixon et al. found a 
positive relationship between public health expenditures and 
health status. Similar results were also obtained in the studies 
conducted by Filmer et al., Rajkumar, and Farahani (16,29–31).
Conclusion
We  used public and private health expenditures in this study. 
As mentioned above, a positive relationship was found between 
public health expenditures and the health status, while no 
significant relationship was observed between private health 
expenditures and the health status. We suggest dividing private 
health expenditures into details in order to find the relationships. 
For example, we can use out of pocket health expenditures and 
private health insurances as independent variables. In this study, 
infant mortality rate was used as indicator of the health status. 
Other indicators, such as crude death rate, life expectancy, and 
health adjusted life expectancy, can also be used as dependent 
variables in further studies in order to indicate the health status. 
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